DataKnowledgeCloudtrainingcoordination

COL Q9UBV2-1 GLY 000040 (Collection)

Taxon:

Homo sapiens

Taxonomy (Entity type)

Protein:

SE1L1 HUMAN

Protein (Entity type)

Project:

Portal

Project (Entity type)

Dcc Asset:

glygen 2026 06 06 C2M2.zip

Processed File (Entity type)

Dcc:

GlyGen

DCC (Entity type)

Compound:

2-acetamido-2-deoxy-alpha-D-galactopyranose

Compound (Entity type)

Collection:

human proteoform glycosylation sites unicarbkb.csv

File (Entity type)

Description:Information for protein Q9UBV2-1 in the context of file GLY_000040

Creation Time:2026-03-02 19:56:34.000000

Results found

Linked to

	Label	Description
	SE1L1 HUMAN Protein (Entity type)	Protein sel-1 homolog 1 (precursor)
	q9ubv2-1 608asn 608asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 431asn 431asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 272asn 272asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 195asn 195asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 217asn 217asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 38thr 38thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 49thr 49thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 50thr 50thr defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification
	q9ubv2-1 44ser 44ser defined go:0006486 go:0006493 Post Translational Modification (Entity type)	A Post Translational Modification

Protein

SE1L1 HUMAN

Protein (Entity type)

Protein sel-1 homolog 1 (precursor)

Post Translational Modification

q9ubv2-1 608asn 608asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 431asn 431asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 272asn 272asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 195asn 195asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 217asn 217asn defined go:0006486 go:0006487

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 38thr 38thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 49thr 49thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 50thr 50thr defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

Post Translational Modification

q9ubv2-1 44ser 44ser defined go:0006486 go:0006493

Post Translational Modification (Entity type)

A Post Translational Modification

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.